Designing and evaluating a patient decision aid for patients with locally advanced or locally recurrent rectal cancer: a national multicentre mixed methods study protocol

INTRODUCTION: Approximately 5%–10% of new rectal cancers are locally advanced (locally advanced rectal cancer (LARC)) at presentation with 4%–8% recurring (locally recurrent rectal cancer (LRRC)) after initial treatment. Patients with potentially curable disease have to consider many trade-offs when...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Anwen, Hutchings, Hayley Anne, Harris, Dean Anthony, Evans, Martyn, Harji, Deena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204455/
https://www.ncbi.nlm.nih.gov/pubmed/35705344
http://dx.doi.org/10.1136/bmjopen-2021-056984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204455/
https://www.ncbi.nlm.nih.gov/pubmed/35705344
http://dx.doi.org/10.1136/bmjopen-2021-056984

Ejemplares similares